Zydus Lifesciences reports double-digit growth in Q2, revenue up 20%
Zydus Lifesciences Ltd shares closed at ₹ 948.95 on NSE on Tuesday following the Q2 results, 2.4% lower than the previous day ...
First Advantage Corporation: First Advantage Reports Third Quarter 2024 Results
Third Quarter 2024 Highlights1 Revenues of $199.1 millionNet Loss of $(8.9) million, a net loss margin of (4.4)%, includes $13.2 million of expenses incurred related to the acquisition of Sterling Che ...
US stock market: the winners and losers one week after the election
Last week's US election spurred big moves in the US stock market, with some global indexes making record highs. Here's how ...
Weekly U.K. Gilt Yield And Pound Sterling Forecast, Nov. 8, 2024: On The Verge Of An Inversion
Read more on forward Gilt rates, yield predictions, exchange rates, and default risk probabilities for investments in the UK ...
Up 41% in 1 year, I’m buying more of this growth trust for my Stocks and Shares ISA
A great performance over the last 12 months has pushed our writer to buy more of a very exciting investment trust for his Stocks and Shares ISA. Paul Summers explains why.